Biotech Series C Investors & VC Firms
9 firms in this list, with a median first check of $1M. 4 of them lead rounds. Generated from verified public data and updated continuously.
Madrona Venture Group
SeattlePre-Seed–Series C
Third Rock Ventures
BostonSeed–Series C
LSP (Life Sciences Partners)
StockholmSeries A–Late Stage$11M – $66M
Medicxi
LondonPre-Seed–Series C
Osage University Partners
Pre-Seed–Late Stage$1M – $20M
Innovestor Ventures
HelsinkiPre-Seed–Growth
Octopus Ventures
LondonPre-Seed–Late Stage$125K
DCVC (Data Collective)
San FranciscoSeed–Late Stage
Andreessen Horowitz
Menlo ParkSeed–Growth
Related lists
Series C Investors & VC Firms (47)Biotech Investors & VC Firms (21)Biotech Seed Investors & VC Firms (16)Biotech Series B Investors & VC Firms (12)Biotech Series A Investors & VC Firms (11)Biotech Pre-Seed Investors & VC Firms (10)Biotech Growth Investors & VC Firms (9)AI & Machine Learning Series C Investors & VC Firms (8)Deep Tech Series C Investors & VC Firms (7)Healthtech Series C Investors & VC Firms (7)
Data sourced from public filings and firms' own websites — see our methodology.